These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23325399)

  • 61. Prediction of Hopeless Peptides Unlikely to be Selected for Targeted Proteome Analysis.
    Matsuda F; Tomita A; Shimizu H
    Mass Spectrom (Tokyo); 2017; 6(1):A0056. PubMed ID: 28580222
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Targeted quantification of low ng/mL level proteins in human serum without immunoaffinity depletion.
    Shi T; Sun X; Gao Y; Fillmore TL; Schepmoes AA; Zhao R; He J; Moore RJ; Kagan J; Rodland KD; Liu T; Liu AY; Smith RD; Tang K; Camp DG; Qian WJ
    J Proteome Res; 2013 Jul; 12(7):3353-61. PubMed ID: 23763644
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Using Data Independent Acquisition (DIA) to Model High-responding Peptides for Targeted Proteomics Experiments.
    Searle BC; Egertson JD; Bollinger JG; Stergachis AB; MacCoss MJ
    Mol Cell Proteomics; 2015 Sep; 14(9):2331-40. PubMed ID: 26100116
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Targeted Mass Spectrometry-Based Approach for Protein-Ligand Binding Analyses in Complex Biological Mixtures Using a Phenacyl Bromide Modification Strategy.
    Jin L; Wang D; Gooden DM; Ball CH; Fitzgerald MC
    Anal Chem; 2016 Nov; 88(22):10987-10993. PubMed ID: 27740755
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum.
    Krastins B; Prakash A; Sarracino DA; Nedelkov D; Niederkofler EE; Kiernan UA; Nelson R; Vogelsang MS; Vadali G; Garces A; Sutton JN; Peterman S; Byram G; Darbouret B; Pérusse JR; Seidah NG; Coulombe B; Gobom J; Portelius E; Pannee J; Blennow K; Kulasingam V; Couchman L; Moniz C; Lopez MF
    Clin Biochem; 2013 Apr; 46(6):399-410. PubMed ID: 23313081
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Plasma preparation to measure FDA-approved protein markers by selected reaction monitoring.
    Kiseleva OI; Romashova YA; Moskaleva NE; Petushkova NA; Teryaeva NB; Belyaev AY; Lisitsa AV
    Clin Transl Med; 2015 Dec; 4(1):32. PubMed ID: 26471814
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impact of Serum and Plasma Matrices on the Titration of Human Inflammatory Biomarkers Using Analytically Validated SRM Assays.
    Dupin M; Fortin T; Larue-Triolet A; Surault I; Beaulieu C; Gouel-Chéron A; Allaouchiche B; Asehnoune K; Roquilly A; Venet F; Monneret G; Lacoux X; Roitsch CA; Pachot A; Charrier JP; Pons S
    J Proteome Res; 2016 Aug; 15(8):2366-78. PubMed ID: 27322794
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry.
    Whiteaker JR; Zhao L; Abbatiello SE; Burgess M; Kuhn E; Lin C; Pope ME; Razavi M; Anderson NL; Pearson TW; Carr SA; Paulovich AG
    Mol Cell Proteomics; 2011 Apr; 10(4):M110.005645. PubMed ID: 21245105
    [TBL] [Abstract][Full Text] [Related]  

  • 69. mProphet: automated data processing and statistical validation for large-scale SRM experiments.
    Reiter L; Rinner O; Picotti P; Hüttenhain R; Beck M; Brusniak MY; Hengartner MO; Aebersold R
    Nat Methods; 2011 May; 8(5):430-5. PubMed ID: 21423193
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of a selected reaction monitoring mass spectrometry-based assay to detect asparaginyl endopeptidase activity in biological fluids.
    Dutta A; Potier DN; Walker MJ; Gray OJ; Parker C; Holland M; Williamson AJ; Pierce A; Unwin RD; Krishnan S; Saha V; Whetton AD
    Oncotarget; 2016 Oct; 7(43):70822-70831. PubMed ID: 27683124
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nonlinear Regression Improves Accuracy of Characterization of Multiplexed Mass Spectrometric Assays.
    Galitzine C; Egertson JD; Abbatiello S; Henderson CM; Pino LK; MacCoss M; Hoofnagle AN; Vitek O
    Mol Cell Proteomics; 2018 May; 17(5):913-924. PubMed ID: 29438992
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of Aptamers as Affinity Reagents for an Enhancement of SRM-Based Detection of Low-Abundance Proteins in Blood Plasma.
    Radko S; Ptitsyn K; Novikova S; Kiseleva Y; Moysa A; Kurbatov L; Mannanova M; Zgoda V; Ponomarenko E; Lisitsa A; Archakov A
    Biomedicines; 2020 May; 8(5):. PubMed ID: 32456365
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anomalies of the structural specificity of peptides.
    WOOLLEY DW; MERRIFIELD RB
    Ann N Y Acad Sci; 1963 Feb; 104():161-71. PubMed ID: 14001849
    [No Abstract]   [Full Text] [Related]  

  • 74. CORLAS group photo 2016.
    Acta Otolaryngol; 2017 Apr; 137(4):338. PubMed ID: 28084149
    [No Abstract]   [Full Text] [Related]  

  • 75. Group photo.
    Adv Biol Regul; 2018 Jan; 67():xi. PubMed ID: 33250165
    [No Abstract]   [Full Text] [Related]  

  • 76. Key to Group photo.
    Adv Biol Regul; 2018 Jan; 67():xii. PubMed ID: 33250166
    [No Abstract]   [Full Text] [Related]  

  • 77. Ultraviolet photodissociation and collision-induced dissociation for qualitative/quantitative analysis of low molecular weight compounds by liquid chromatography-mass spectrometry.
    Giraud R; Le Blanc YJC; Guna M; Hopfgartner G
    Anal Bioanal Chem; 2023 Dec; 415(29-30):7117-7126. PubMed ID: 37803134
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Specific detection of protein carbonylation sites by 473 nm photodissociation mass spectrometry.
    Ladouce R; MacAleese L; Wittine K; Merćep M; Girod M
    Anal Bioanal Chem; 2023 Nov; 415(27):6619-6632. PubMed ID: 37755489
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ultraviolet Photodissociation Mass Spectrometry for Analysis of Biological Molecules.
    Brodbelt JS; Morrison LJ; Santos I
    Chem Rev; 2020 Apr; 120(7):3328-3380. PubMed ID: 31851501
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tailored photocleavable peptides: fragmentation and neutralization pathways in high vacuum.
    Debiossac M; Schätti J; Kriegleder M; Geyer P; Shayeghi A; Mayor M; Arndt M; Köhler V
    Phys Chem Chem Phys; 2018 Apr; 20(16):11412-11417. PubMed ID: 29645042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.